Brazil suspends Bharat Biotech’s Covaxin order over graft allegations
Team Udayavani, Jun 30, 2021, 11:26 AM IST
Hyderabad: The Brazilian government, which agreed to purchase 20 million doses of Bharat Biotech’s COVID-19 vaccine Covaxin, on Wednesday announced suspension of the contract following allegations of irregularities in the deal.
“By recommendation of @CGUonline, we decided to temporarily suspend the Covaxin contract.
According to CGU’s preliminary analysis, there are no irregularities in the contract, but, due to compliance, the @minsaude opted to suspend the contract for further analysis,” Brazil Health Minister Marcelo Queiroga tweeted.
The Covaxin contract to Brazil landed in controversy after the South American countrys Attorney General reportedly launched a probe into the deal.
“It is noteworthy that the @govbr did not pay ANY CENT for the Covaxin vaccine. The measure does not compromise the pace of the vaccination campaign against #Covid19 in Brazil, since there is no approval from Anvisa for emergency or definitive use of the immunizing agent,” Queiroga said in another tweet.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Intruder killed along India-Pakistan border in Rajasthan
Kazakhstan says 42 people likely dead in Azerbaijan Airlines’ plane crash
Killed in Russia-Ukraine war six months ago, UP man’s body brought back home
‘We should try again’: Punjab Assembly Speaker on Vajpayee’s failed India-Pak peace initiative
Delhi Police crackdown on illegal immigration of Bangladeshi citizens, 11 arrested
MUST WATCH
Latest Additions
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.